In wake of Hwang scandal, report suggests journal should apply extra scrutiny to papers likely to garner lots of public attention

A conversation with forensic anthropologist Kathy Reichs, whose best-selling Temperance Brennan mystery novels were the inspiration for the Fox television series Bones

FEATUREHuman Interactome Project Making Money from the InteractomeBY KATE FODOR© THOM GRAVESAs companies consider their roles in the massive human interactome project, they are keeping in mind some hard-learned lessons. Chief among their case studies is Celera Genomics, which proved that databases cannot, per se, be a firm's main revenue source. "Companies don't talk anymore about the raw data they can amass fo

Early this year, Harvard University President Lawrence Summers made his now-famous remarks speculating that female scientists may have difficulty winning tenured faculty positions because of differences in "intrinsic aptitude."

When Vivian Pinn was 4 years old, she announced that one day she would be a doctor.

The word "minority" is becoming a misnomer in many parts of the United States.

The US Securities and Exchange Commission recently launched a formal investigation into possible insider trading at the Cambridge, Mass.-based biotechnology firm Biogen Idec.

For Lori Klaman, the fight against diabetes is a personal one.

No two days are quite the same," says Deborah Hartman, director of lead discovery in central nervous system and pain research at AstraZeneca in Wilmington, Del. Hartman, who started out as a bench scientist, is now a manager in charge of about 50 people working together on discovering new drugs for CNS disease targets.

When Iain Webb left his job as medical director at Boston's Dana-Farber Cancer Institute for Millennium Pharmaceuticals three and a half years ago, he found industry to be "a different world," he recalls.

As a young man at the height of the Vietnam War, Bogdan Dziurzynski had to make a choice.

Jamie Stacey rises before dawn most days, and she and her 17-month-old son arrive at Abbott Laboratories' headquarters before 7:00 A.M.

Justin Provchy had been accepted to two PhD programs in mathematics when he received a package of information about Claremont, Calif.-based Keck Graduate Institute's master of bioscience degree.

Johnson, Amgen, Schering-Plough, Bristol-Myers Squibb, and Abbott in an attempt to get the firms to stop using five common animal tests.

When a working map of the human genome was announced in June 2000, it was immediately clear that it would open new avenues of study and transform the life sciences, both in academia and in industry.